ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Research Report 2026
Published Date: 2026-04-24
|
Report Code: QYRE-Auto-1Y3173
Home | Market Reports
Global Phosphodiesterase Type 5 PDE5 Inhibitor Market Insights Forecast to 2028
BUY CHAPTERS

Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Research Report 2026

Code: QYRE-Auto-1Y3173
Report
2026-04-24
Pages:116
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Eli Lilly
Pfizer Inc
Bayer
BaiYunShan General Factory
SK Chemicals
Teva Pharma
Seoul Pharma
Jiangsu Yabang
VIVUS
Fujian Cosunter
Youcare Pharmaceutical

Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size

The global Phosphodiesterase Type 5 (PDE5) Inhibitor market was valued at US$ 2423 million in 2025 and is anticipated to reach US$ 2869 million by 2032, at a CAGR of 2.5% from 2026 to 2032.

Phosphodiesterase Type 5 (PDE5) Inhibitor Market

Phosphodiesterase Type 5 (PDE5) Inhibitor Market

Phosphodiesterase type 5 (PDE5) inhibitor is a class of medication that specifically targets and blocks the enzyme phosphodiesterase type 5. This enzyme is primarily found in the smooth muscle cells of the blood vessels, including those in the penis and lungs. By inhibiting PDE5, these medications promote the accumulation of cyclic guanosine monophosphate (cGMP), a chemical responsible for relaxing the smooth muscles and increasing blood flow in these areas. In the context of erectile dysfunction (ED), PDE5 inhibitors help improve blood flow to the penis, facilitating and maintaining erections. They are also used in the treatment of pulmonary arterial hypertension (PAH) to reduce blood vessel constriction and lower blood pressure in the lungs.
The key players of Phosphodiesterase Type 5 (PDE5) Inhibitor include Eli Lilly, Pfizer and Bayer, etc. The top three players hold a share over 65%. Asia-Pacific is the largest market, has a share about 34%. In terms of product type, Sildenafil is the largest segment, occupied for a share of about 72%, and for application ,and in terms of application, Retail Pharmacy has a share about 49%.
This report delivers a comprehensive overview of the global Phosphodiesterase Type 5 (PDE5) Inhibitor market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Phosphodiesterase Type 5 (PDE5) Inhibitor. The Phosphodiesterase Type 5 (PDE5) Inhibitor market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Phosphodiesterase Type 5 (PDE5) Inhibitor market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Phosphodiesterase Type 5 (PDE5) Inhibitor manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Phosphodiesterase Type 5 (PDE5) Inhibitor Market Report

Report Metric Details
Report Name Phosphodiesterase Type 5 (PDE5) Inhibitor Market
Accounted market size in 2025 US$ 2423 million
Forecasted market size in 2032 US$ 2869 million
CAGR 2.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Sildenafil
  • Tadalafil
  • Avanafil
  • Vardenafil
  • Others
Segment by Application
  • Hospital
  • Retail Pharmacy
  • Online Pharmacies
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, Teva Pharma, SK Chemicals, Seoul Pharma, Jiangsu Yabang, VIVUS, Fujian Cosunter, Youcare Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Phosphodiesterase Type 5 (PDE5) Inhibitor companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Phosphodiesterase Type 5 (PDE5) Inhibitor Market growing?

Ans: The Phosphodiesterase Type 5 (PDE5) Inhibitor Market witnessing a CAGR of 2.5% during the forecast period 2026-2032.

What is the Phosphodiesterase Type 5 (PDE5) Inhibitor Market size in 2032?

Ans: The Phosphodiesterase Type 5 (PDE5) Inhibitor Market size in 2032 will be US$ 2869 million.

What is the market share of major companies in Phosphodiesterase Type 5 (PDE5) Inhibitor Market?

Ans: The top three players hold a share over 65%.

What is the Phosphodiesterase Type 5 (PDE5) Inhibitor Market share by region?

Ans: Asia-Pacific is the largest market, has a share about 34%.

What is the Phosphodiesterase Type 5 (PDE5) Inhibitor Market share by type?

Ans: In terms of product type, Sildenafil is the largest segment, occupied for a share of about 72%, and for application ,and in terms of application, Retail Pharmacy has a share about 49%.

Who are the main players in the Phosphodiesterase Type 5 (PDE5) Inhibitor Market report?

Ans: The main players in the Phosphodiesterase Type 5 (PDE5) Inhibitor Market are Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, Teva Pharma, SK Chemicals, Seoul Pharma, Jiangsu Yabang, VIVUS, Fujian Cosunter, Youcare Pharmaceutical

What are the Application segmentation covered in the Phosphodiesterase Type 5 (PDE5) Inhibitor Market report?

Ans: The Applications covered in the Phosphodiesterase Type 5 (PDE5) Inhibitor Market report are Hospital, Retail Pharmacy, Online Pharmacies, Other

What are the Type segmentation covered in the Phosphodiesterase Type 5 (PDE5) Inhibitor Market report?

Ans: The Types covered in the Phosphodiesterase Type 5 (PDE5) Inhibitor Market report are Sildenafil, Tadalafil, Avanafil, Vardenafil, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Avanafil
1.2.5 Vardenafil
1.2.6 Others
1.3 Market by Application
1.3.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacies
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Perspective (2021–2032)
2.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Growth Trends by Region
2.2.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Historic Market Size by Region (2021–2026)
2.2.3 Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Region (2027–2032)
2.3 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Dynamics
2.3.1 Phosphodiesterase Type 5 (PDE5) Inhibitor Industry Trends
2.3.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Drivers
2.3.3 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Challenges
2.3.4 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Phosphodiesterase Type 5 (PDE5) Inhibitor Players by Revenue
3.1.1 Global Top Phosphodiesterase Type 5 (PDE5) Inhibitor Players by Revenue (2021–2026)
3.1.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Players (2021–2026)
3.2 Global Top Phosphodiesterase Type 5 (PDE5) Inhibitor Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue
3.4 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Concentration Ratio
3.4.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in 2025
3.5 Global Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor Head Offices and Areas Served
3.6 Global Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor, Products and Applications
3.7 Global Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Phosphodiesterase Type 5 (PDE5) Inhibitor Breakdown Data by Type
4.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Historic Market Size by Type (2021–2026)
4.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Type (2027–2032)
5 Phosphodiesterase Type 5 (PDE5) Inhibitor Breakdown Data by Application
5.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Historic Market Size by Application (2021–2026)
5.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2021–2032)
6.2 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2021–2026)
6.4 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2021–2032)
7.2 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2021–2026)
7.4 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2021–2032)
8.2 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2021–2026)
8.4 Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2021–2032)
9.2 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2021–2026)
9.4 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2021–2032)
10.2 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2021–2026)
10.4 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.1.4 Eli Lilly Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2021–2026)
11.1.5 Eli Lilly Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.2.4 Pfizer Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2021–2026)
11.2.5 Pfizer Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.3.4 Bayer Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2021–2026)
11.3.5 Bayer Recent Development
11.4 BaiYunShan General Factory
11.4.1 BaiYunShan General Factory Company Details
11.4.2 BaiYunShan General Factory Business Overview
11.4.3 BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.4.4 BaiYunShan General Factory Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2021–2026)
11.4.5 BaiYunShan General Factory Recent Development
11.5 Teva Pharma
11.5.1 Teva Pharma Company Details
11.5.2 Teva Pharma Business Overview
11.5.3 Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.5.4 Teva Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2021–2026)
11.5.5 Teva Pharma Recent Development
11.6 SK Chemicals
11.6.1 SK Chemicals Company Details
11.6.2 SK Chemicals Business Overview
11.6.3 SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.6.4 SK Chemicals Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2021–2026)
11.6.5 SK Chemicals Recent Development
11.7 Seoul Pharma
11.7.1 Seoul Pharma Company Details
11.7.2 Seoul Pharma Business Overview
11.7.3 Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.7.4 Seoul Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2021–2026)
11.7.5 Seoul Pharma Recent Development
11.8 Jiangsu Yabang
11.8.1 Jiangsu Yabang Company Details
11.8.2 Jiangsu Yabang Business Overview
11.8.3 Jiangsu Yabang Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.8.4 Jiangsu Yabang Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2021–2026)
11.8.5 Jiangsu Yabang Recent Development
11.9 VIVUS
11.9.1 VIVUS Company Details
11.9.2 VIVUS Business Overview
11.9.3 VIVUS Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.9.4 VIVUS Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2021–2026)
11.9.5 VIVUS Recent Development
11.10 Fujian Cosunter
11.10.1 Fujian Cosunter Company Details
11.10.2 Fujian Cosunter Business Overview
11.10.3 Fujian Cosunter Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.10.4 Fujian Cosunter Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2021–2026)
11.10.5 Fujian Cosunter Recent Development
11.11 Youcare Pharmaceutical
11.11.1 Youcare Pharmaceutical Company Details
11.11.2 Youcare Pharmaceutical Business Overview
11.11.3 Youcare Pharmaceutical Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.11.4 Youcare Pharmaceutical Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2021–2026)
11.11.5 Youcare Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Eli Lilly
Pfizer Inc
Bayer
BaiYunShan General Factory
SK Chemicals
Teva Pharma
Seoul Pharma
Jiangsu Yabang
VIVUS
Fujian Cosunter
Youcare Pharmaceutical
List of Tables
 Table 1. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Sildenafil
 Table 3. Key Players of Tadalafil
 Table 4. Key Players of Avanafil
 Table 5. Key Players of Vardenafil
 Table 6. Key Players of Others
 Table 7. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 9. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (US$ Million), 2021–2026
 Table 10. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Region (2021–2026)
 Table 11. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 12. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Region (2027–2032)
 Table 13. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Trends
 Table 14. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Drivers
 Table 15. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Challenges
 Table 16. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Restraints
 Table 17. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue by Players (US$ Million), 2021–2026
 Table 18. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Players (2021–2026)
 Table 19. Global Top Phosphodiesterase Type 5 (PDE5) Inhibitor Players by Tier (Tier 1, Tier 2, and Tier 3), based on Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue, 2025
 Table 20. Ranking of Global Top Phosphodiesterase Type 5 (PDE5) Inhibitor Companies by Revenue (US$ Million) in 2025
 Table 21. Global 5 Largest Players Market Share by Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (CR5 and HHI), 2021–2026
 Table 22. Global Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor, Headquarters and Area Served
 Table 23. Global Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor, Products and Applications
 Table 24. Global Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor, Date of General Availability (GA)
 Table 25. Mergers and Acquisitions, Expansion Plans
 Table 26. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (US$ Million), 2021–2026
 Table 27. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Type (2021–2026)
 Table 28. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 29. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Type (2027–2032)
 Table 30. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (US$ Million), 2021–2026
 Table 31. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Application (2021–2026)
 Table 32. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 33. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Application (2027–2032)
 Table 34. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (US$ Million), 2021–2026
 Table 36. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (US$ Million), 2027–2032
 Table 37. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (US$ Million), 2021–2026
 Table 39. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (US$ Million), 2027–2032
 Table 40. Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (US$ Million), 2021–2026
 Table 42. Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (US$ Million), 2027–2032
 Table 43. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (US$ Million), 2021–2026
 Table 45. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (US$ Million), 2027–2032
 Table 46. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 47. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (US$ Million), 2021–2026
 Table 48. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (US$ Million), 2027–2032
 Table 49. Eli Lilly Company Details
 Table 50. Eli Lilly Business Overview
 Table 51. Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Product
 Table 52. Eli Lilly Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (US$ Million), 2021–2026
 Table 53. Eli Lilly Recent Development
 Table 54. Pfizer Company Details
 Table 55. Pfizer Business Overview
 Table 56. Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Product
 Table 57. Pfizer Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (US$ Million), 2021–2026
 Table 58. Pfizer Recent Development
 Table 59. Bayer Company Details
 Table 60. Bayer Business Overview
 Table 61. Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Product
 Table 62. Bayer Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (US$ Million), 2021–2026
 Table 63. Bayer Recent Development
 Table 64. BaiYunShan General Factory Company Details
 Table 65. BaiYunShan General Factory Business Overview
 Table 66. BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Product
 Table 67. BaiYunShan General Factory Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (US$ Million), 2021–2026
 Table 68. BaiYunShan General Factory Recent Development
 Table 69. Teva Pharma Company Details
 Table 70. Teva Pharma Business Overview
 Table 71. Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product
 Table 72. Teva Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (US$ Million), 2021–2026
 Table 73. Teva Pharma Recent Development
 Table 74. SK Chemicals Company Details
 Table 75. SK Chemicals Business Overview
 Table 76. SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Product
 Table 77. SK Chemicals Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (US$ Million), 2021–2026
 Table 78. SK Chemicals Recent Development
 Table 79. Seoul Pharma Company Details
 Table 80. Seoul Pharma Business Overview
 Table 81. Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product
 Table 82. Seoul Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (US$ Million), 2021–2026
 Table 83. Seoul Pharma Recent Development
 Table 84. Jiangsu Yabang Company Details
 Table 85. Jiangsu Yabang Business Overview
 Table 86. Jiangsu Yabang Phosphodiesterase Type 5 (PDE5) Inhibitor Product
 Table 87. Jiangsu Yabang Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (US$ Million), 2021–2026
 Table 88. Jiangsu Yabang Recent Development
 Table 89. VIVUS Company Details
 Table 90. VIVUS Business Overview
 Table 91. VIVUS Phosphodiesterase Type 5 (PDE5) Inhibitor Product
 Table 92. VIVUS Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (US$ Million), 2021–2026
 Table 93. VIVUS Recent Development
 Table 94. Fujian Cosunter Company Details
 Table 95. Fujian Cosunter Business Overview
 Table 96. Fujian Cosunter Phosphodiesterase Type 5 (PDE5) Inhibitor Product
 Table 97. Fujian Cosunter Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (US$ Million), 2021–2026
 Table 98. Fujian Cosunter Recent Development
 Table 99. Youcare Pharmaceutical Company Details
 Table 100. Youcare Pharmaceutical Business Overview
 Table 101. Youcare Pharmaceutical Phosphodiesterase Type 5 (PDE5) Inhibitor Product
 Table 102. Youcare Pharmaceutical Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (US$ Million), 2021–2026
 Table 103. Youcare Pharmaceutical Recent Development
 Table 104. Research Programs/Design for This Report
 Table 105. Key Data Information from Secondary Sources
 Table 106. Key Data Information from Primary Sources
 Table 107. Authors List of This Report


List of Figures
 Figure 1. Phosphodiesterase Type 5 (PDE5) Inhibitor Picture
 Figure 2. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type: 2025 vs 2032
 Figure 4. Sildenafil Features
 Figure 5. Tadalafil Features
 Figure 6. Avanafil Features
 Figure 7. Vardenafil Features
 Figure 8. Others Features
 Figure 9. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (US$ Million), 2021–2032
 Figure 10. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application: 2025 vs 2032
 Figure 11. Hospital Case Studies
 Figure 12. Retail Pharmacy Case Studies
 Figure 13. Online Pharmacies Case Studies
 Figure 14. Other Case Studies
 Figure 15. Phosphodiesterase Type 5 (PDE5) Inhibitor Report Years Considered
 Figure 16. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 17. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 18. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Region: 2025 vs 2032
 Figure 19. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Players in 2025
 Figure 20. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 21. The Top 10 and 5 Players Market Share by Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in 2025
 Figure 22. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Country (2021–2032)
 Figure 24. United States Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Canada Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Country (2021–2032)
 Figure 28. Germany Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. France Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. U.K. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Italy Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Russia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Ireland Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Region (2021–2032)
 Figure 36. China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Japan Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. South Korea Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Southeast Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. India Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Australia & New Zealand Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Country (2021–2032)
 Figure 44. Mexico Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Brazil Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Country (2021–2032)
 Figure 48. Israel Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Saudi Arabia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 50. UAE Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 51. Eli Lilly Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2021–2026)
 Figure 52. Pfizer Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2021–2026)
 Figure 53. Bayer Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2021–2026)
 Figure 54. BaiYunShan General Factory Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2021–2026)
 Figure 55. Teva Pharma Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2021–2026)
 Figure 56. SK Chemicals Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2021–2026)
 Figure 57. Seoul Pharma Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2021–2026)
 Figure 58. Jiangsu Yabang Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2021–2026)
 Figure 59. VIVUS Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2021–2026)
 Figure 60. Fujian Cosunter Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2021–2026)
 Figure 61. Youcare Pharmaceutical Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2021–2026)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Apremilast API Market Research Report 2024
Global Phosphodiesterase PDE inhibitors Market Insights Forecast to 2030
Global PDE3 PDE4 Inhibitors Market Research Report 2024
Global Avanafil API Market Research Report 2025
Global Vardenafil Market Insights Forecast to 2030
Global Tadalafil Oral Market Insights Forecast to 2030
Global Tadalafil API Market Research Report 2025
Global 5α Reductase Inhibitors Market Research Report 2025
Global Udenafil Market Research Report 2025
Global PDE Inhibitors Market Research Report 2024
Global Milrinone Reagent Market Research Report 2024
Global Papaverine Hydrochloride Injection Market Insights Forecast to 2030
Global Milrinone API Market Research Report 2024
Amrinone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Erectile Dysfunction Treatment Market Insights Forecast to 2030
Global Phosphodiesterase Inhibitor Market Research Report 2025
Protoporphyrinogen Oxidase Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Endothelin Antagonists Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Erectile Dysfunction Oral Medications Market Research Report 2025
Global VEGF Inhibitors Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions